We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Nitrostat 0.3mg sublingual tablets (Canada)
Section 19A approved medicine
(Approval lapsed) Nitrostat 0.3mg sublingual tablets (Canada)
Section 19A approval holder
Pfizer Australia Pty Ltd ABN 50 008 422 348
Upjohn Australia Pty Ltd ABN 50 629 389 911
Upjohn Australia Pty Ltd ABN 50 629 389 911
Phone
1800 675 229
Approved until
Status
Expired
Medicines in short supply/unavailable
ANGININE glyceryl trinitrate 600microgram tablet bottle - ARTG 227783
LYCINATE glyceryl trinitrate 600microgram tablet bottle - ARTG 227784
LYCINATE glyceryl trinitrate 600microgram tablet bottle - ARTG 227784
Indication(s)
NITROSTAT is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.